Abstract:
Biomarkers and related methods of using the biomarkers to identify subjects at risk of losing lean body mass during a prolonged period of physical inactivity are provided. The biomarkers may be blood biomarkers and include Tissue Inhibitor of Metalloprotease-1 (TIMP-1), Tenascin C (TNC), and Apolipoprotein A2 (ApoA-2). Also provided is a method of treating subjects at risk of losing lean body mass during a prolonged period of physical inactivity.
Abstract:
Insulin resistance biomarkers and related methods of using the biomarkers are provided. The biomarkers may be blood biomarkers and include C-peptide, Insulin-Like Growth Factor- Binding Protein 2 (IGFBP-2), and Leptin. Also provided is a method of reducing the effect of prolonged physical inactivity on insulin resistance in a subject who is experiencing prolonged physical inactivity, or who is expected to experience prolonged physical inactivity in the near future.
Abstract:
Insulin resistance biomarkers and related methods of using the biomarkers are provided. The biomarkers may be blood biomarkers and include C-peptide, Insulin-Like Growth Factor- Binding Protein 2 (IGFBP-2), and Leptin. Also provided is a method of reducing the effect of prolonged physical inactivity on insulin resistance in a subject who is experiencing prolonged physical inactivity, or who is expected to experience prolonged physical inactivity in the near future.